Advertisement

Topics

Cimzia's Phase III Data First In Non-Radiographic Axial Spondyloarthritis

07:06 EDT 17 May 2018 | SCRIP

Top-line Phase III data suggests UCB Pharma's Cimzia has benefits in a specific type of axial spondyloarthrits, with the findings...

      

Related Stories

 

Original Article: Cimzia's Phase III Data First In Non-Radiographic Axial Spondyloarthritis

NEXT ARTICLE

More From BioPortfolio on "Cimzia's Phase III Data First In Non-Radiographic Axial Spondyloarthritis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...